Doug Flora

Debra Patt, an oncology leader and chair of ASCO's AI task force, joins Doug Flora, a community oncology expert, to dive into the transformative effects of AI in cancer care. They discuss the barriers to AI adoption, emphasizing that change management is more critical than the technology itself. The pair also tackle Medicare's AI policies, the importance of clinical decision support, and the need for diverse training data to address bias. Their insights spotlight the balance between innovation and patient safety in a rapidly evolving healthcare landscape.